在创伤性脑损伤期间,干细胞之外的外体:作还是希望?
Mehrdad Hajinejad1, Mahsa Abedi2, Sajad Sahab Negah3
1Qaen Faculty of Medical Sciences, Birjand University of Medical Sciences, Birjand, Iran.
Brain injury
|June 11, 2025
概括
干细胞疗法通过促进再生,显示了大脑损伤恢复的前景. 源自干细胞的外体细胞比传统疗法具有潜在的优势,克服了免疫反应和创伤性脑损伤治疗的生物可用性等局限性.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 干细胞疗法对神经创伤,特别是创伤性脑损伤 (TBI) 提出了有前途的治疗方法.
- 干细胞促进神经再生,并通过旁观者效应,细胞替代和激活内源途径改善神经结果.
- 干细胞治疗脑损伤的临床应用在有效性和标准化方面存在局限性.
研究的目的:
- 审查干细胞及其外体在治疗脑损伤中的应用.
- 为了检查干细胞和外体细胞之间的治疗区别,用于脑损伤.
- 突出外体治疗对创伤性脑损伤的潜力.
主要方法:
- 对相关数据库进行广泛的文献审查.
- 在脑损伤中利用有针对性的关键词来提取关于干细胞和外体的信息.
- 分析了治疗策略,并将干细胞衍生的外体与干细胞进行了比较.
主要成果:
- 外体作为细胞外囊泡,可以克服干细胞治疗的局限性,如生物可用性差和免疫反应.
- 来自干细胞的外体细胞在克服与传统干细胞治疗相关的障碍方面显示出显著的潜力.
- 审查发现了干细胞和外体细胞之间的治疗方法的关键差异.
结论:
- 外体细胞疗法正在成为基于干细胞治疗脑损伤的重大进展.
- 进一步的研究是必不可少的,以充分阐明外体在脑损伤中的治疗机制.
- 外体为创伤性脑损伤的干细胞治疗提供了一个有希望的替代方案或辅助方案.
更多相关视频
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
4.2K
09:29Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells
Published on: July 10, 2019
10.8K
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
